| Ident. | Authors (with country if any) | Title |
|---|
| 000007 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
| 000012 (2020) |
E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique] | [Coronavirus and COVID-19 : focus on a galopping pandemic]. |
| 000017 (2020) |
Heinz Flamm [Autriche] | [Anno 1529 - the "English Sweating Sickness" in Vienna, the Turkish troops around Vienna]. |
| 000025 (2020) |
Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite] | Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. |
| 000035 (2020) |
Yaseen M. Arabi [Arabie saoudite] ; Ayed Y. Asiri [Arabie saoudite] ; Abdullah M. Assiri [Arabie saoudite] ; Hani A. Aziz Jokhdar [Arabie saoudite] ; Adel Alothman [Arabie saoudite] ; Hanan H. Balkhy [Arabie saoudite] ; Sameera Aljohani [Arabie saoudite] ; Shmeylan Al Harbi [Arabie saoudite] ; Suleiman Kojan [Arabie saoudite] ; Majed Al Jeraisy [Arabie saoudite] ; Ahmad M. Deeb [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] ; Sameeh Ghazal [Arabie saoudite] ; Sarah Al Faraj [Arabie saoudite] ; Fahad Al-Hameed [Arabie saoudite] ; Asim Alsaedi [Arabie saoudite] ; Yasser Mandourah [Arabie saoudite] ; Ghaleb A. Al Mekhlafi [Arabie saoudite] ; Nisreen Murad Sherbeeni [Arabie saoudite] ; Fatehi Elnour Elzein [Arabie saoudite] ; Abdullah Almotairi [Arabie saoudite] ; Ali Al Bshabshe [Arabie saoudite] ; Ayman Kharaba [Arabie saoudite] ; Jesna Jose [Arabie saoudite] ; Abdulrahman Al Harthy [Arabie saoudite] ; Mohammed Al Sulaiman [Arabie saoudite] ; Ahmed Mady [Arabie saoudite, Égypte] ; Robert A. Fowler [Canada] ; Frederick G. Hayden ; Abdulaziz Al-Dawood [Arabie saoudite] ; Mohamed Abdelzaher [Arabie saoudite, Égypte] ; Wail Bajhmom [Arabie saoudite] ; Mohamed A. Hussein [Arabie saoudite] | Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial |
| 000044 (2020) |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
| 000047 (2020) |
Salah T. Al Awaidy [Oman] ; Ali Abdullah Al Maqbali [Oman] ; Iyad Omer [Oman] ; Suad Al Mukhaini [Oman] ; Mohammed Ali Al Risi [Oman] ; Majed Sultan Al Maqbali [Oman] ; Ali Al Reesi [Oman] ; Mujahid Al Busaidi [Oman] ; Fatma Hashim Al Hashmi [Oman] ; Talib Khamis Al Maqbali [Oman] ; Vidyanand Vaidya [Oman] ; Elham Said Ahmed Al Risi [Oman] ; Talib Khamis Al Maqbali [Oman] ; Ahmed Abdullah Rashid [Oman] ; Maryam Abdullah Hassan Al Beloshi [Oman] ; Arash Etemadi [Oman] ; Faryal Khamis [Oman] | The first clusters of Middle East respiratory syndrome coronavirus in Oman: Time to act |
| 000055 (2020) |
Noah C. Peeri [États-Unis] ; Nistha Shrestha [États-Unis] ; Md Siddikur Rahman [Bangladesh] ; Rafdzah Zaki [Malaisie] ; Zhengqi Tan [États-Unis] ; Saana Bibi [Pakistan] ; Mahdi Baghbanzadeh [Iran] ; Nasrin Aghamohammadi [Malaisie] ; Wenyi Zhang [République populaire de Chine] ; Ubydul Haque [États-Unis] | The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| 000056 (2020) |
Muhammad Umer Nasir [Canada] ; James Roberts [Canada] ; Nestor L. Muller [Canada] ; Francesco Macri [Canada] ; Mohammed F. Mohammed [Arabie saoudite] ; Shahram Akhlaghpoor [Iran] ; William Parker [Canada] ; Arash Eftekhari [Canada] ; Susan Rezaei [Iran] ; John Mayo [Canada] ; Savvas Nicolaou [Canada] | The Role of Emergency Radiology in COVID-19: From Preparedness to Diagnosis. |
| 000060 (2020) |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
| 000062 (2020) |
Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. |
| 000071 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000078 (2020) |
Mahmoud Kandeel [Arabie saoudite] ; Mizuki Yamamoto [Japon] ; Abdulla Al-Taher [Arabie saoudite] ; Aya Watanabe [Japon] ; Kentaro Oh-Hashi [Japon] ; Byoung Kwon Park [Corée du Sud] ; Hyung-Joo Kwon [Corée du Sud] ; Jun-Ichiro Inoue [Japon] ; Mohammed Al-Nazawi [Arabie saoudite] | Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers. |
| 000079 (2020) |
Nicholas Easom [Royaume-Uni] ; Peter Moss [Royaume-Uni] ; Gavin Barlow [Royaume-Uni] ; Anda Samson [Royaume-Uni] ; Thomas Taynton [Royaume-Uni] ; Kate Adams [Royaume-Uni] ; Monica Ivan [Royaume-Uni] ; Phillipa Burns [Royaume-Uni] ; Kavitha Gajee [Royaume-Uni] ; Kirstine Eastick [Royaume-Uni] ; Patrick J. Lillie [Royaume-Uni] | Sixty-eight consecutive patients assessed for COVID-19 infection: Experience from a UK Regional infectious diseases Unit. |
| 000096 (2020) |
Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie] | Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
| 000097 (2020) |
Shuntong Kang [République populaire de Chine] ; Wenyao Peng [République populaire de Chine] ; Yuhao Zhu [République populaire de Chine] ; Shiyao Lu [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Wenfang Wu [République populaire de Chine] ; Shu Huang [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment |
| 000102 (2020) |
Hanaa Zakaria Nooh ; Rawan Humaidy Alshammary ; Jomanh Mohammed Alenezy ; Njood Hial Alrowaili ; Amani Jaded Alsharari ; Njood Menwer Alenzi ; Hanan E. Sabaa | Public awareness of coronavirus in Al-Jouf region, Saudi Arabia |
| 000115 (2020) |
Frederick M. Burkle | Political Intrusions into the International Health Regulations Treaty and Its Impact on Management of Rapidly Emerging Zoonotic Pandemics: What History Tells Us. |
| 000123 (2020) |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000140 (2020) |
Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine] | Molecular immune pathogenesis and diagnosis of COVID-19 |
| 000141 (2020) |
Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Shihui Sun [République populaire de Chine] ; Wanbo Tai [États-Unis] ; Jing Chen [République populaire de Chine] ; Qibin Geng [États-Unis] ; Lei He [République populaire de Chine] ; Yuehong Chen [République populaire de Chine] ; Jianming Wu [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] ; Fang Li [États-Unis] | Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. |
